Tickerlog
NASDAQ
$6.85
-99.990
-4.503
Updated Sunday 2nd of January 2022 02:35:09 PM

Achieve Life Sciences Inc. Common Shares

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
EBITDA $
ROE -99.990
EPS -4.503
Marketcap$64.8M
Free Cash Flow$
Health Care
Biotechnology: In Vitro & In Vivo Diagnostic Substances

Top gainers today
Top losers today